Cargando…

The colorectal cancer immune paradox revisited

Tumor infiltrating lymphocytes (TILs) represent a strong independent predictor of relapse and overall survival in colorectal cancer (CRC). However, it appears that a majority of CRCs, i.e., microsatellite stable (MSS) tumors, are refractory to immune checkpoint blockers. The results of recent compre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelova, Mihaela, Charoentong, Pornpimol, Hackl, Hubert, Trajanoski, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801462/ https://www.ncbi.nlm.nih.gov/pubmed/27057454 http://dx.doi.org/10.1080/2162402X.2015.1078058

Ejemplares similares

Bioinformatics for cancer immunology and immunotherapy
por: Charoentong, Pornpimol, et al.
Publicado: (2012)

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
por: Angelova, Mihaela, et al.
Publicado: (2015)

Mathematical models for translational and clinical oncology
por: Gallasch, Ralf, et al.
Publicado: (2013)

The paradox of dicer in cancer
por: Swahari, Vijay, et al.
Publicado: (2016)

Evasion before invasion: Pre-cancer immunosurveillance
por: Angelova, Mihaela, et al.
Publicado: (2021)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014)

Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020)

Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022)

Leptin revisited: The role of leptin in starvation
por: Perry, Rachel J.
Publicado: (2018)

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
por: Thibaudin, Marion, et al.
Publicado: (2023)

Revisiting glucose metabolism in cancer: lessons from a PKM knock-in model
por: Sato, Taku, et al.
Publicado: (2018)

The paradox of Prader-Willi syndrome revisited: Making sense of the phenotype
por: Holland, Anthony, et al.
Publicado: (2022)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

Macrophages: Good guys in colorectal cancer
por: Edin, Sofia, et al.
Publicado: (2013)

Personalized peptide vaccination for advanced colorectal cancer
por: Sasada, Tetsuro, et al.
Publicado: (2015)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer
por: Iskar, Murat, et al.
Publicado: (2015)

Toll-like receptor genetic variants and colorectal cancer
por: Weber, Alexander NR, et al.
Publicado: (2014)

BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

Stromal CEACAM1 expression regulates colorectal cancer metastasis
por: Arabzadeh, Azadeh, et al.
Publicado: (2012)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Targeting copper metabolism to defeat KRAS-driven colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020)

Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
por: Kesselring, Rebecca, et al.
Publicado: (2012)

DDR1 inhibition as a new therapeutic strategy for colorectal cancer
por: Sirvent, Audrey, et al.
Publicado: (2018)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition
por: Popova, Semiramis A., et al.
Publicado: (2018)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Tumor conditioned media from colorectal cancer patients inhibits dendritic cell maturation
por: Michielsen, Adriana J., et al.
Publicado: (2012)

The peripheral immune response and lung cancer prognosis
por: Showe, Michael K., et al.
Publicado: (2012)

A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

"Flagellated" cancer cells propel anti-tumor immunity
por: Garaude, Johan, et al.
Publicado: (2012)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021)

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
por: Bindea, Gabriela, et al.
Publicado: (2009)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015)

Hormesis in cancer immunology: Does the quantity of an immune reactant matter?
por: Pearce, Oliver MT, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_88ffpqb16ochm4atf568pu3hf1